PROGRESSIVENESS AND GENERALIZABILITY OF THE EFFECTS OF ALENDRONATE ON BONE MASS AND SAFETY EXPERIENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

被引：0
|
作者：
EMKEY, R
CORREAROTTER, R
SANTORA, A
LOMBARDI, A
DAIFOTIS, A
机构：
[1] READING MED CTR,BONE RES CTR,W READING,PA 19610
[2] NATL INST NUTR,MEXICO CITY,DF,MEXICO
[3] MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065
来源：
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1239 / 1239
页数：1
相关论文
共 50 条
  • [31] Cyclical alendronate treatment in postmenopausal women with osteoporosis
    Kösüs, A
    Çapar, M
    Kösüs, N
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) : 182 - 184
  • [32] Alendronate improves QOL of postmenopausal women with osteoporosis
    Kawate, Hisaya
    Ohnaka, Keizo
    Adachi, Masahiro
    Kono, Suminori
    Ikematsu, Hideyuki
    Matsuo, Hisashi
    Higuchi, Kazumi
    Takayama, Takehiko
    Takayanagi, Ryoichi
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 123 - 131
  • [33] Randomized study comparing the effect on bone mass of Calcitriol or Alendronate with or without HRT in postmenopausal women with osteopenia or osteoporosis
    Casas, PF
    Delgado, E
    Vieder, C
    Gil, AB
    Bellman, D
    Delfino, M
    Mirkin, A
    Martino, M
    Paciocco, M
    Lopez, C
    Saenz, G
    Sottano, J
    Vidal, DR
    9TH INTERNATIONAL MENOPAUSE SOCIETY WORLD CONGRESS ON THE MENOPAUSE, 1999, : 91 - 94
  • [34] EFFECTS OF ARZOXIFENE ON FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS OR WITH LOW BONE MASS
    Reginster, J. Y.
    McClung, M.
    Cox, D.
    Mitlak, B.
    Stock, J.
    Amewou-Atisso, M.
    Miller, P.
    Christiansen, C.
    Cummings, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 23 - 24
  • [35] Comparison of biochemical markers of bone remodelling in the assessment of the effects of alendronate on bone in postmenopausal osteoporosis
    Stepán, JJ
    Vokrouhlická, J
    CLINICA CHIMICA ACTA, 1999, 288 (1-2) : 121 - 135
  • [36] Effects of Bazedoxifene on Bone Mineral Density, Bone Turnover, and Safety in Postmenopausal Japanese Women With Osteoporosis
    Itabashi, Akira
    Yoh, Kousei
    Chines, Arkadi A.
    Miki, Takami
    Takada, Masahiko
    Sato, Hiroshi
    Gorai, Itsuo
    Sugimoto, Toshitsugu
    Mizunuma, Hideki
    Ochi, Hiroshi
    Constantine, Ginger D.
    Ohta, Hiroaki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 519 - 529
  • [37] Effect of alendronate on bone density and bone markers in postmenopausal osteoporosis
    Aki, S
    Gulbaba, RG
    Eskiyurt, N
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2003, 17 (01) : 27 - 31
  • [38] Treatment with 5 mg alendronate in postmenopausal women with low bone mass
    Moggia, S
    Sayegh, F
    Otero, A
    Man, Z
    RECENT RESEARCH IN GYNECOLOGICAL ENDOCRINOLOGY, 2001, : 225 - 226
  • [39] Denosumab and Alendronate Have Different Effects at the Ultradistal Radius in Postmenopausal Women With Low Bone Mass
    Libanati, Cesar
    Seeman, Ego
    Thomas, Thierry
    Boyd, Steven
    Boutroy, Stephanie
    Shane, Elizabeth
    Hanley, David
    Bogado, Cesar
    Cheung, Angela
    Majumdar, Sharmila
    Sellmayer, Deborah
    Kearns, Ann
    Delmas, Pierre
    Fan, Michelle
    Zanchetta, Jose
    BONE, 2010, 46 : S28 - S29
  • [40] Effects of alendronate therapy on the bone mineral density in postmenopausal women
    Savoca, S
    Nardo, LG
    D'Agosta, S
    Messina, K
    Rosano, T
    Pignatello, R
    Nardo, F
    RECENT RESEARCH IN GYNECOLOGICAL ENDOCRINOLOGY, 2001, : 231 - 234
12345